The global wound antifungals market is projected to grow from USD 744.1 million in 2025 to USD 1337.3 million by 2035, at a CAGR of 6.0%. By product type, topical azoles will lead with a 34.5% market share, while by application, diabetic foot ulcers will dominate with a 31% share in 2025.